Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

from Perspectives by the Leerink Center for Pharmacoeconomics · host The Leerink Center for Pharmacoeconomics

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute where they discuss drug prices, their opportunity costs, and the effect today’s prices have on future drug developments.

Episode metadata supplied by the publisher feed · Published Mar 26, 2025

Embed this episode

Attribution link and audio player

Ready to play

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

0:00 25:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Perspectives by the Leerink Center for Pharmacoeconomics?

This episode is 25 minutes long.

When was this Perspectives by the Leerink Center for Pharmacoeconomics episode published?

This episode was published on March 26, 2025.

Can I download this Perspectives by the Leerink Center for Pharmacoeconomics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!